Alternate-Day Buprenorphine. Phase V - 6

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status and phase

Completed
Phase 1

Conditions

Opioid-Related Disorders

Treatments

Drug: Buprenorphine

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000224
NIDA-06969-6
R01-06969-6

Details and patient eligibility

About

The purpose of this study is to evaluate buprenorphine blockade challenge.

Sex

All

Ages

30 to 49 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems